{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:39:20Z","timestamp":1786991960337,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jcv.2015.11.022","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T21:30:32Z","timestamp":1447882232000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Performance of 14 rubella IgG immunoassays on samples with low positive or negative haemagglutination inhibition results"],"prefix":"10.1016","volume":"74","author":[{"given":"Daniela","family":"Huzly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Hanselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Neumann-Haefelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Panning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2015.11.022_bib0005","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jmv.23757","article-title":"Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women","volume":"86","author":"Barlinn","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0010","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.vaccine.2014.01.066","article-title":"Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage","volume":"32","author":"Smits","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.11.022_bib0015","unstructured":"Coyle P. Viral Congenital and Neonate Infections ESCV Book of Abstracts 2014; Keynote lecture at the ESCV congress in Prague 2014"},{"key":"10.1016\/j.jcv.2015.11.022_bib0020","unstructured":"W.H.O. The Immunological Basis for Immunization Series. Immunization, Vaccines and Biologicals 2008, Module 11: Rubella: 1\u201325"},{"key":"10.1016\/j.jcv.2015.11.022_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/659838","article-title":"Rubella immunity among pregnant women in Jeddah, Western Region of Saudi Arabia","volume":"2014","author":"Alsibiani","year":"2014","journal-title":"Obstet. Gynecol. Int."},{"key":"10.1016\/j.jcv.2015.11.022_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/09674845.2014.11669975","article-title":"Rubella antibody status of patients attending a south-west London antenatal clinic, 2007\u20132012","volume":"71","author":"Mortlock","year":"2014","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.jcv.2015.11.022_bib0035","first-page":"1","article-title":"Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"47","author":"Watson","year":"1998","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.jcv.2015.11.022_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CVI.05334-11","article-title":"Persistence and titer changes of rubella virus antibodies in primiparous women who had been vaccinated with strain RA 27\/3 in Junior High School","volume":"19","author":"Lin","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0045","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1128\/JCM.00719-06","article-title":"Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen","volume":"44","author":"Sauerbrei","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0050","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1016\/j.vaccine.2008.08.074","article-title":"Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination","volume":"26","author":"Cohen","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.11.022_bib0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/106.2.170","article-title":"Rubella immunity defining the level of protective antibody","volume":"106","author":"Skendzel","year":"1996","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0022172400069308","article-title":"Are many women immunized against rubella unnecessarily?","volume":"87","author":"Mortimer","year":"1981","journal-title":"J. Hyg."},{"key":"10.1016\/j.jcv.2015.11.022_bib0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S0022172400026711","article-title":"Rubella antibody measured by radial hemolysis\u2014characteristics and performance of a simle screening method for use in diagnostic laboratories","volume":"84","author":"Kurtz","year":"1980","journal-title":"J. Hyg."},{"key":"10.1016\/j.jcv.2015.11.022_bib0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/JCM.17.1.28-34.1983","article-title":"Single radial hemolysis test for rubella immunity and recent infection","volume":"17","author":"Neumann","year":"1983","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0075","series-title":"Aspects of Antibody Quantification in Rubella- and CMV-serology","author":"Pustowoit","year":"1994"},{"key":"10.1016\/j.jcv.2015.11.022_bib0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/CVI.00603-12","article-title":"Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays","volume":"20","author":"Dimech","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/JCM.30.3.633-641.1992","article-title":"Multicenter evaluation of five commercial rubella virus immunoglobulin G kits which report in international units per milliliter","volume":"30","author":"Dimech","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0090","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/JCM.00231-08","article-title":"Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter","volume":"46","author":"Dimech","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/vim.2010.0026","article-title":"A qualitative and quantitative comparison of two rubella virus-specific IgG antibody immunoassays","volume":"23","author":"Greenwood","year":"2010","journal-title":"Viral Immunol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/JCM.16.1.82-85.1982","article-title":"Comparison of several test systems used for determination of rubella immune status","volume":"16","author":"Weissfeld","year":"1982","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0105","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/JCM.13.5.850-854.1981","article-title":"Comparison of hemagglutination inhibition test and enzyme-linked immunosorbent assay for determining antibody to rubella virus","volume":"13","author":"Shekarchi","year":"1981","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/JCM.21.2.161-163.1985","article-title":"Comparative evaluation of commercial rubella virus antibody kits","volume":"21","author":"Wittenburg","year":"1985","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0115","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/CVI.00688-12","article-title":"Performance of the elecsys rubella IgG assay in the diagnostic laboratory setting for assessment of immune status","volume":"20","author":"Enders","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1017\/S0022172400025262","article-title":"The derivation of a minimum immune titre of rubella haemagglutination-inhibition (HI) antibody. A Public Health Laboratory Service Collaborative survey","volume":"81","author":"Bradstreet","year":"1978","journal-title":"J. Hyg. (Lond.)"},{"key":"10.1016\/j.jcv.2015.11.022_bib0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0928-0197(94)90005-1","article-title":"Rubella reinfection; role of neutralising antibodies and cell-mediated immunity","volume":"2","author":"O'Shea","year":"1994","journal-title":"Clin. Diagn. Virol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1386-6532(99)00048-7","article-title":"Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells","volume":"14","author":"Nedeljkovic","year":"1999","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01311038","article-title":"Immune responses to wild and vaccine rubella viruses after rubella vaccination","volume":"106","author":"Cusi","year":"1989","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0140","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/JCM.30.4.824-830.1992","article-title":"Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays","volume":"30","author":"Zhang","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0145","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/CDLI.8.4.785-787.2001","article-title":"Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems","volume":"8","author":"Diepersloot","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0150","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/JCM.13.5.818-823.1981","article-title":"Nonspecific reactions in the hemagglutination inhibition test for detection of rubella antibodies","volume":"13","author":"Budzko","year":"1981","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0155","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02123736","article-title":"Identification of non-specific serum inhibitors of rubella virus haemagglutination","volume":"159","author":"Blom","year":"1974","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0160","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.11.022_bib0165","unstructured":"PAHO\/WHO, Elimination of rubella and congenital rubella syndrome in the Americas, PAHO Fact sheet 2015, April."},{"key":"10.1016\/j.jcv.2015.11.022_bib0170","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.02430-07","article-title":"Comparison of nine commercially available assays for quantification of antibody response to hepatitis B virus surface antigen","volume":"46","author":"Huzly","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0175","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ajog.2014.05.046","article-title":"Rubella monitoring in pregnancy as a means for evaluating a possible reemergence of rubella","volume":"211","author":"Hutton","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jcv.2015.11.022_bib0180","unstructured":"STIKO am RKI Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand, August 2015, Epidemiologisches Bulletin 2015, Nr 34."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T11:14:32Z","timestamp":1599822872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653215007568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":36,"alternative-id":["S1386653215007568"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2015.11.022","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of 14 rubella IgG immunoassays on samples with low positive or negative haemagglutination inhibition results","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2015.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}